ReviewEuropean heart journal. Cardiovascular pharmacotherapy2026

From stabilization to silencing in transthyretin amyloid cardiomyopathy: why sequencing should be treat-to-trajectory, not 'one-and-done'.

Arif Albulushi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.